BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 33549135)

  • 1. Hematopoietic stem cell transplantation for systemic sclerosis: Brazilian experience.
    Henrique-Neto Á; Vasconcelos MYK; Dias JBE; de Moraes DA; Gonçalves MS; Zanin-Silva DC; Zucoloto TG; de Oliveira MFC; Dotoli GM; Weffort LF; Leopoldo VC; Oliveira MC
    Adv Rheumatol; 2021 Feb; 61(1):9. PubMed ID: 33549135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors for treatment-related mortality and major adverse events after autologous haematopoietic stem cell transplantation for systemic sclerosis: results of a long-term follow-up multicentre study.
    van Bijnen S; de Vries-Bouwstra J; van den Ende CH; Boonstra M; Kroft L; Geurts B; Snoeren M; Schouffoer A; Spierings J; van Laar JM; Huizinga TW; Voskuyl A; Marijt E; van der Velden W; van den Hoogen FH; Vonk MC
    Ann Rheum Dis; 2020 Aug; 79(8):1084-1089. PubMed ID: 32409324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis.
    Burt RK; Oliveira MC; Shah SJ; Moraes DA; Simoes B; Gheorghiade M; Schroeder J; Ruderman E; Farge D; Chai ZJ; Marjanovic Z; Jain S; Morgan A; Milanetti F; Han X; Jovanovic B; Helenowski IB; Voltarelli J
    Lancet; 2013 Mar; 381(9872):1116-24. PubMed ID: 23363664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease.
    Binks M; Passweg JR; Furst D; McSweeney P; Sullivan K; Besenthal C; Finke J; Peter HH; van Laar J; Breedveld FC; Fibbe WE; Farge D; Gluckman E; Locatelli F; Martini A; van den Hoogen F; van de Putte L; Schattenberg AV; Arnold R; Bacon PA; Emery P; Espigado I; Hertenstein B; Hiepe F; Kashyap A; Kötter I; Marmont A; Martinez A; Pascual MJ; Gratwohl A; Prentice HG; Black C; Tyndall A
    Ann Rheum Dis; 2001 Jun; 60(6):577-84. PubMed ID: 11350846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial.
    Burt RK; Shah SJ; Dill K; Grant T; Gheorghiade M; Schroeder J; Craig R; Hirano I; Marshall K; Ruderman E; Jovanovic B; Milanetti F; Jain S; Boyce K; Morgan A; Carr J; Barr W
    Lancet; 2011 Aug; 378(9790):498-506. PubMed ID: 21777972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous Hematological Stem Cell Transplantation for Systemic Sclerosis in Israel.
    Rimar D; Butbul Aviel Y; Gefen A; Nevo N; Shen-Orr SS; Starosvetsky E; Rosner I; Rozenbaum M; Kaly L; Boulman N; Slobodin G; Zuckerman T
    Isr Med Assoc J; 2020 Feb; 22(2):104-110. PubMed ID: 32043328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of autologous haematopoietic stem cell transplantation in systemic sclerosis: a systematic review of the literature.
    Eyraud A; Scouppe L; Barnetche T; Forcade E; Lazaro E; Duffau P; Richez C; Seneschal J; Truchetet ME;
    Br J Dermatol; 2018 Mar; 178(3):650-658. PubMed ID: 28906550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in Japan.
    Ayano M; Tsukamoto H; Mitoma H; Kimoto Y; Akahoshi M; Arinobu Y; Miyamoto T; Horiuchi T; Niiro H; Nagafuji K; Harada M; Akashi K
    Arthritis Res Ther; 2019 Jan; 21(1):30. PubMed ID: 30670057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous haematopoietic stem cell transplantation for Japanese patients with systemic sclerosis: Long-term follow-up on a phase II trial and treatment-related fatal cardiomyopathy.
    Nakamura H; Odani T; Yasuda S; Noguchi A; Fujieda Y; Kato M; Oku K; Bohgaki T; Sugita J; Endo T; Teshima T; Atsumi T
    Mod Rheumatol; 2018 Sep; 28(5):879-884. PubMed ID: 29251023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell transplant in systemic sclerosis: An Indian experience.
    Nair V; Vasdev V; Kumar A; Shankar S; Nair V; Sharma A
    Int J Rheum Dis; 2018 Apr; 21(4):859-865. PubMed ID: 29392863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative chest CT analysis in patients with systemic sclerosis before and after autologous stem cell transplantation: comparison of results with those of pulmonary function tests and clinical tests.
    Kloth C; Maximilian Thaiss W; Preibsch H; Mark K; Kötter I; Hetzel J; Nikolaou K; Henes J; Horger M
    Rheumatology (Oxford); 2016 Oct; 55(10):1763-70. PubMed ID: 27330164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interstitial lung disease associated with systemic sclerosis (SSc-ILD).
    Cottin V; Brown KK
    Respir Res; 2019 Jan; 20(1):13. PubMed ID: 30658650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of autologous stem cell transplantation for systemic sclerosis -- a single-center longterm experience in 26 patients with severe organ manifestations.
    Henes JC; Schmalzing M; Vogel W; Riemekasten G; Fend F; Kanz L; Koetter I
    J Rheumatol; 2012 Feb; 39(2):269-75. PubMed ID: 22247352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis With Marked Improvement in Health-Related Quality of Life.
    Maltez N; Puyade M; Wang M; Lansiaux P; Marjanovic Z; Charles C; Steele R; Baron M; Colmegna I; Hudson M; Farge D;
    Arthritis Rheumatol; 2021 Feb; 73(2):305-314. PubMed ID: 32909693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis.
    Vonk MC; Marjanovic Z; van den Hoogen FH; Zohar S; Schattenberg AV; Fibbe WE; Larghero J; Gluckman E; Preijers FW; van Dijk AP; Bax JJ; Roblot P; van Riel PL; van Laar JM; Farge D
    Ann Rheum Dis; 2008 Jan; 67(1):98-104. PubMed ID: 17526554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous hematopoietic stem cell transplantation improves long-term survival-data from a national registry.
    Blank N; Schmalzing M; Moinzadeh P; Oberste M; Siegert E; Müller-Ladner U; Riemekasten G; Günther C; Kötter I; Zeidler G; Pfeiffer C; Juche A; Jandova I; Ehrchen J; Susok L; Schmeiser T; Sunderkötter C; Distler JHW; Worm M; Kreuter A; Keyßer G; Lorenz HM; Krieg T; Hunzelmann N; Henes J;
    Arthritis Res Ther; 2022 Nov; 24(1):258. PubMed ID: 36424638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes in progressive systemic sclerosis treated with autologous hematopoietic stem cell transplantation compared with combination therapy.
    Keret S; Henig I; Zuckerman T; Kaly L; Shouval A; Awisat A; Rosner I; Rozenbaum M; Boulman N; Dortort Lazar A; Molad Y; Sabbah F; Naffaa ME; Hardak E; Slobodin G; Rimar D
    Rheumatology (Oxford); 2024 May; 63(6):1534-1538. PubMed ID: 37672021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of Systemic Sclerosis-Associated Interstitial Lung Disease One Year After Hematopoietic Stem Cell Transplantation or Cyclophosphamide.
    Ciaffi J; van Leeuwen NM; Boonstra M; Kroft LJM; Schouffoer AA; Ninaber MK; Huizinga TWJ; de Vries-Bouwstra JK
    Arthritis Care Res (Hoboken); 2022 Mar; 74(3):433-441. PubMed ID: 32961038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term immune reconstitution and T cell repertoire analysis after autologous hematopoietic stem cell transplantation in systemic sclerosis patients.
    Farge D; Arruda LC; Brigant F; Clave E; Douay C; Marjanovic Z; Deligny C; Maki G; Gluckman E; Toubert A; Moins-Teisserenc H
    J Hematol Oncol; 2017 Jan; 10(1):21. PubMed ID: 28103947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry.
    Farge D; Passweg J; van Laar JM; Marjanovic Z; Besenthal C; Finke J; Peter HH; Breedveld FC; Fibbe WE; Black C; Denton C; Koetter I; Locatelli F; Martini A; Schattenberg AV; van den Hoogen F; van de Putte L; Lanza F; Arnold R; Bacon PA; Bingham S; Ciceri F; Didier B; Diez-Martin JL; Emery P; Feremans W; Hertenstein B; Hiepe F; Luosujärvi R; Leon Lara A; Marmont A; Martinez AM; Pascual Cascon H; Bocelli-Tyndall C; Gluckman E; Gratwohl A; Tyndall A;
    Ann Rheum Dis; 2004 Aug; 63(8):974-81. PubMed ID: 15249325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.